Quality · Access · Hope
Countries

🇿🇦 #5 Export Destination

South Africa

Major pharmaceutical partnership with South Africa

$751M FY 2025–26

India ships $751M in pharmaceutical products to South Africa each year, making it the #5 export destination. The vast majority are finished medicines, drug formulations ready for dispensing.

All data from DGCIS India export records (fiscal year, April–March).
$751M
Scale
India supplies $751M in pharmaceutical products to South Africa each year, a substantial supply line of affordable medicine.
91%
Medicine
Overwhelmingly finished medicines, drug formulations account for 91% of shipments.
1.6×
Trajectory
India's pharmaceutical supply to South Africa has grown 1.6× over the past decade, strong, sustained expansion.
#5
Context
India's #5 pharmaceutical export destination, among the top five globally.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in South Africa, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $683M (90.9%) Medicine Ingredients $25.7M (3.4%) Vaccines $20.3M (2.7%) Surgical & Hospital Supplies $12.6M (1.7%) Traditional & Herbal $9.7M (1.3%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in South Africa Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into South Africa: $457M across 45 filings (2011-2025).